Sarm
Also known as: SARMs, ligandrol, testolone, ostarine, LGD-4033, RAD-140, Enobosarm, GTx-024, MK-0773, PF-06260414, GSK2881078, OPK-88004, Selective Androgen Receptor Modulators
Overview
Selective Androgen Receptor Modulators (SARMs) are a class of synthetic compounds designed to selectively activate androgen receptors primarily in muscle and bone tissues. This selective binding aims to promote anabolic effects, such as increased muscle mass and bone density, while minimizing the androgenic side effects typically associated with traditional anabolic steroids, such as prostate enlargement or virilization. SARMs are not naturally occurring substances. They are currently investigational anabolic agents, primarily studied for their potential in treating muscle wasting diseases, osteoporosis, and sarcopenia. Despite ongoing research, no SARM has received FDA approval for clinical use. However, they are illicitly used for performance enhancement and bodybuilding. The available evidence, while including several randomized controlled trials, often comes from studies with small sample sizes and short durations, and significant safety concerns have been reported, limiting their widespread clinical adoption.
Benefits
SARMs have demonstrated several potential benefits, primarily in increasing lean muscle mass and strength. Clinical trials with compounds like LGD-4033 and GTx-024, at doses ranging from 0.1 to 3 mg daily, have shown increases in lean mass of approximately 1-3 kg over 12 weeks. Improvements in physical performance measures, such as stair climb power and leg press strength, have also been reported with moderate to large effect sizes over 12-16 weeks. These benefits are particularly observed in populations experiencing muscle loss, such as older adults, postmenopausal women, and patients with sarcopenia or chronic obstructive pulmonary disease (COPD). Beyond muscle, SARMs also show potential for improving bone density and overall physical function in these vulnerable populations. While statistically significant, the clinical relevance of these functional improvements can vary. Benefits typically become apparent within 8-12 weeks of consistent use.
How it works
SARMs exert their effects by selectively binding to androgen receptors (ARs) in the body. Unlike traditional anabolic steroids, which activate ARs broadly across various tissues, SARMs are designed to preferentially activate ARs in muscle and bone cells. This tissue-selective modulation promotes anabolic pathways, leading to increased protein synthesis and muscle growth, while minimizing activation in androgen-sensitive tissues like the prostate, skin, and hair follicles. This selectivity is intended to reduce the androgenic side effects commonly associated with conventional steroids. SARMs are generally orally bioavailable, and their specific pharmacokinetic profiles, including absorption and half-life, vary among different compounds.
Side effects
The overall safety profile of SARMs is a significant concern, and their recreational use is associated with considerable risks. Common side effects, reported in over 5% of users, include elevated liver enzymes, which can indicate liver injury (hepatotoxicity), suppression of endogenous testosterone production, and alterations in lipid profiles (e.g., changes in cholesterol levels). Less common side effects (1-5%) include tendon damage and mild gastrointestinal symptoms. Rare but severe adverse events (<1%) have been reported, such as rhabdomyolysis and severe liver injury, including cases of acute liver failure, as well as tendon rupture. Due to their unapproved status, data on drug interactions are limited, but potential interactions with other hepatotoxic drugs and hormonal therapies are a concern. SARMs are contraindicated in individuals with pre-existing liver disease, those at risk for prostate cancer, or individuals with cardiovascular disease. Their use in athletes is prohibited by anti-doping agencies, and recreational users face higher risks due to unregulated dosing and product purity issues.
Dosage
Clinical trials have explored a range of SARM dosages, with measurable effects observed at doses as low as 0.1 mg per day for compounds like LGD-4033. Optimal dosage ranges typically fall between 0.1 and 3 mg per day, depending on the specific SARM and the intended purpose. A maximum safe dose has not been established, and higher doses are generally associated with an increased risk of adverse events. Dosing is commonly administered daily, with study durations ranging from 8 to 16 weeks. SARMs are primarily studied in oral formulations. Absorption factors can vary, with some compounds showing improved absorption when taken with food. There are no established required cofactors for SARM efficacy.
FAQs
Are SARMs safe for bodybuilding?
No, SARMs are not safe for bodybuilding. Evidence indicates significant risks, including liver injury, tendon damage, and hormonal imbalances, especially with unregulated recreational use.
Do SARMs suppress natural testosterone?
Yes, suppression of endogenous testosterone production is a commonly reported side effect of SARM use, which can lead to hormonal imbalances.
How quickly do SARMs work?
Muscle mass and strength gains from SARMs typically begin to appear within 8-12 weeks of consistent use, based on clinical study observations.
Are SARMs legal?
No, SARMs are not approved drugs for human use and are banned by major sports organizations like WADA and the US Department of Defense due to safety concerns and performance-enhancing effects.
Can SARMs cause permanent damage?
Cases of severe liver injury and tendon rupture suggest that SARM use has the potential to cause serious and potentially permanent harm to various organ systems.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC10204391/ – This systematic review of case reports highlights significant safety concerns associated with SARM use, particularly drug-induced liver injury (DILI), rhabdomyolysis, and tendon rupture. It notes that LGD-4033 and RAD-140 are among the most frequently implicated SARMs in adverse event reports, underscoring the risks of recreational use.
- https://onlinelibrary.wiley.com/doi/10.1111/cen.15135 – This systematic review of 9 randomized controlled trials (RCTs) found that SARMs increased lean mass and strength in various patient populations, including those with sarcopenia, cancer, and COPD. However, it also identified safety concerns such as liver enzyme elevations and noted that no SARMs had received FDA approval, emphasizing the need for further safety data.
- https://pubmed.ncbi.nlm.nih.gov/39755947/ – This systematic review focusing on SARM abuse in athletes confirms their use for muscle gain but also details a range of severe adverse effects, including hepatotoxicity, cardiotoxicity, androgenic effects, and testosterone suppression. The review underscores the significant health risks associated with SARM use in athletic populations.
Supplements Containing Sarm
Natadrol
LG Sciences

Natadrol
LG Sciences

SARM Ostarine MK-2866
DNA Pharma

Lean Mass
RS Formulations

Super SARM LGD
Anabolic Outlaws

Chui Pen Cao
Herbal Terra

Chui Pen Cao
Herbal Terra

FLIGHT PRE-WORKOUT
BPN® BARE PERFORMANCE NUTRITION
![Shr3d [MK-2866 / GW-501516 / SR-9009] by MATRIX LABS](/_next/image?url=https%3A%2F%2Fcdn.purerawz.co%2Fwp-content%2Fuploads%2F2022%2F06%2FPhenibut-HCL-60ml-250mg-3-4-1-800x800.webp&w=3840&q=75&dpl=dpl_EPsoVwoCGxvZKH9D4rpB3hnTVACv)
Shr3d [MK-2866 / GW-501516 / SR-9009]
MATRIX LABS